TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
$ENH · Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes
now playing · $ENH
$ALNY···bullish· high· poschristian angermayer
Angermayer co-founded Alnylam on RNAi thesis, took public via SPAC at 25
RNAi technology could switch off genetic disease expression at the root cause, addressing a multi-billion dollar market with no existing treatments for genetic diseases.
$ATAI···bullish· high· poschristian angermayer
Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry
Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with…
$APEIRON-INVESTMENT-GROUPneutral· high· poschristian angermayer
Angermayer's family office Apeiron invests across lifecycle, seeds funds, and builds companies
Apeiron manages Angermayer's capital plus outside money, doing direct investments from seed to public equities, investing in third-party funds for diversification, and incubating…
$ENH···bullish· high· poschristian angermayer
Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and…
$CMPS···bullish· high· poschristian angermayer
Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy
Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.